Goosebumps, Good day. Hope you all have enjoyed
Post# of 148110
Good day. Hope you all have enjoyed as much as possible the Thanksgiving weekend.
Good set of questions. All very valid & relevant.
For me, the big elephant in the room is Oncology.
Question: can you give us an update in the original EIND patients and those in the basket trial ???
Please remember that a six month increase in OS is deemed a success in Oncology. A CTC reduction will lead indefectibly to such clinical outcome.
We don't have to discover the cure for cancer. We have to probe we have a "signal" as NP put it the other day.
This will be humongous for any company (be it a BP or a pre-revenue) and for cancer sufferers. Global yearly market is around $150 Billion (with B).
So ... please NP tell us something about our cancer patients.